Four-year study of intermittent cyclic etidronate treatment of postmenopausal osteoporosis: Three years of blinded therapy followed by one year of open therapy
- 31 December 1993
- journal article
- clinical trial
- Published by Elsevier in The American Journal of Medicine
- Vol. 95 (6), 557-567
- https://doi.org/10.1016/0002-9343(93)90350-x
Abstract
No abstract availableThis publication has 17 references indexed in Scilit:
- The effects of etidronate on trabecular bone remodeling in postmenopausal spinal osteoporosis: A randomized study comparing intermittent treatment and an ADFR regimeBone, 1991
- Intermittent Cyclical Etidronate Treatment of Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Intermittent Cyclical Etidronate Therapy on Bone Mass and Fracture Rate in Women with Postmenopausal OsteoporosisNew England Journal of Medicine, 1990
- Effect of Fluoride Treatment on the Fracture Rate in Postmenopausal Women with OsteoporosisNew England Journal of Medicine, 1990
- Cyclic therapy of osteoporosis with neutral phosphate and brief, high-dose pulses of etidronateJournal of Bone and Mineral Research, 1989
- Effects of cyclical therapy for osteoporosis using an oral regimen of inorganic phosphate and sodium etidronate: a clinical and bone histomorphometric studyBone and Mineral, 1989
- A randomized study on the effects of estrogen/gestagen or high dose oral calcium on trabecular bone remodeling in postmenopausal osteoporosisBone, 1989
- Diminished Rates of Bone Formation in Normal Black AdultsNew England Journal of Medicine, 1988
- Local and Systemic Factors in the Pathogenesis of OsteoporosisNew England Journal of Medicine, 1988
- Decreased Risk of Fractures of the Hip and Lower Forearm with Postmenopausal Use of EstrogenNew England Journal of Medicine, 1980